HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$21.15
Day range
$16.53 - $19.38
Year range
$6.01 - $25.29
Market cap
1.49B USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 81.73M | 97.54% |
Operating expense | 72.84M | 13.41% |
Net income | -41.23M | 69.70% |
Net profit margin | -50.44 | 84.66% |
Earnings per share | -0.19 | 87.42% |
EBITDA | -29.87M | 53.25% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 322.24M | -26.94% |
Total assets | 548.80M | -17.29% |
Total liabilities | 515.98M | -12.47% |
Total equity | 32.82M | — |
Shares outstanding | 88.80M | — |
Price to book | 57.16 | — |
Return on assets | -18.67% | — |
Return on capital | -23.87% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -41.23M | 69.70% |
Cash from operations | -42.19M | 64.54% |
Cash from investing | 41.29M | -60.64% |
Cash from financing | 3.72M | 808.19% |
Net change in cash | 3.36M | 122.53% |
Free cash flow | -40.30M | -36.16% |
About
Founded
2008
Website
Employees
385
